Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU)

The Institut für Klinische Molekularbiologie (IKMB) in Kiel was founded by Kiel University within the University Hospital Schleswig-Holstein in 2003. It is the vision of the Institute to create a systemic understanding of complex human diseases as well as the phenotype of healthy ageing by using genomic technologies. This includes validating the resulting models at the molecular level (in vitro/in vivo) and their translation into the human diagnostic or therapeutic experiment.

The Institute is cooperatively led by a team of three directors.